Viewing StudyNCT00396812



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00396812
Status: TERMINATED
Last Update Posted: 2013-02-12
First Post: 2006-11-06

Brief Title: Rituximab for the Treatment of Early Rheumatoid Arthritis RA
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Autoimmune disease View
Biologic response modifiers View
Disease-modifying antirheumatic drugs DMARDS View
Immune system View
Rheumatoid arthritis RA View
Rituximab anti-CD20 monoclonal antibodies View